Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Phase 2b Trial of the PDE10A Inhibitor MK-8189 in People With an Acute Episode of Schizophrenia.
Journal: Journal of clinical psychopharmacology
Published: September 08, 2025
Burden of EPS in commercial patients with schizophrenia initiating atypical antipsychotics.
Journal: The American journal of managed care
Published: September 19, 2022
The incidence and economic burden of extrapyramidal symptoms in patients with schizophrenia treated with second generation antipsychotics in a Medicaid population.
Journal: Journal of medical economics
Published: December 16, 2021
A Randomized, Double-blind, Placebo-controlled Proof-of-Concept Trial to Evaluate the Efficacy and Safety of Non-racemic Amisulpride (SEP-4199) for the Treatment of Bipolar I Depression.
Journal: Journal of affective disorders
Published: August 24, 2021
Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial.
Journal: International clinical psychopharmacology
Published: March 16, 2021
Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial.
Journal: CNS spectrums
Published: May 20, 2020
A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia.
Journal: The New England journal of medicine
Published: April 16, 2020
Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.
Journal: Translational psychiatry
Published: October 04, 2019
Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study.
Journal: Journal of attention disorders
Published: August 04, 2019
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.
Journal: Translational psychiatry
Published: March 21, 2019
Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial.
Journal: Journal of child and adolescent psychopharmacology
Published: January 30, 2019
The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia.
Journal: Journal of psychopharmacology (Oxford, England)
Published: January 16, 2019
Last Updated: 09/26/2026